CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands	Total	Synq3, Inc	Amelia Technologies, LLC	As Previously Reported	Equity Line Of Credit Program	Common Stock	Common Stock As Previously Reported	Common Stock Class A Common Stock	Preferred Stock	Preferred Stock Conversion Of Convertible Preferred Stock	Additional Paid-in Capital	Additional Paid-in Capital Synq3, Inc	Additional Paid-in Capital Amelia Technologies, LLC	Additional Paid-in Capital Conversion Of Convertible Preferred Stock	Additional Paid-in Capital Class A Common Stock	Additional Paid-in Capital Equity Line Of Credit Program	Accumulated Other Comprehensive Loss	Accumulated Deficit	Class A Common Stock	Class A Common Stock Common Stock	Class A Common Stock Common Stock Synq3, Inc	Class A Common Stock Common Stock Amelia Technologies, LLC	Class A Common Stock Common Stock Conversion Of Class B Common Stock	Class A Common Stock Common Stock Conversion Of Convertible Preferred Stock	Class A Common Stock Common Stock Class A Common Stock	Class A Common Stock Common Stock Equity Line Of Credit Program	Class B Common Stock	Class B Common Stock Common Stock	Class B Common Stock Common Stock Conversion Of Class B Common Stock
Balance at the beginning (in shares) at Dec. 31, 2021				106,949,326
Balance at the beginning at Dec. 31, 2021				$ 279,503
Increase (Decrease) in Temporary Equity [Roll Forward]
Effect of reverse recapitalization, net of costs (in shares)	(106,949,326)
Effect of reverse recapitalization, net of costs	$ (279,503)
Balance at the ending (in shares) at Dec. 31, 2022				0
Balance at the end at Dec. 31, 2022				$ 0
Balance at the beginning (in shares) at Dec. 31, 2021							68,258,556													0								0
Balance at the beginning at Dec. 31, 2021	$ (343,237)						$ 1		$ 0		$ 43,491						$ 0	$ (386,729)		$ 0								$ 0
Balance at the beginning (in shares) at Dec. 31, 2021									0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)	3,595,706					2,582,535																			1,013,171
Stock Issued During Period, Value, Stock Options Exercised	$ 2,840										2,840				$ 1,320				$ 1,320
Net exercise of outstanding warrants (in shares)						673,416
Conversion of convertible note (in shares)						2,046,827
Conversion of convertible note	20,239										20,239
Effect of reverse recapitalization, net of costs (in shares)						(73,561,334)														140,114,060								40,396,600
Effect of reverse recapitalization, net of costs	279,503					$ (1)					279,486									$ 14								$ 4
PIPE financing (in shares)																				11,300,000
PIPE financing	86,585										86,584									$ 1
Issuance of Class A common shares pursuant to the business combination (in shares)																				4,693,050
Stock issued in acquisitions	4,106										4,105									$ 1
Issuance of Class A common shares upon conversion of Class B common shares (in shares)																							661,192						(661,192)
Stock issued during period, shares, restricted stock award, net of forfeitures (in shares)																				2,516,191
Stock-based compensation											28,792
Net loss	(116,713)			$ (115,373)														(116,713)
Balance at the end (in shares) at Dec. 31, 2022							0													160,297,664								39,735,408
Balance at the end at Dec. 31, 2022	$ (36,565)						$ 0		$ 0		466,857						0	(503,442)		$ 16								$ 4
Balance at the ending (in shares) at Dec. 31, 2022									0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)	3,585,829																			3,585,829
Stock Issued During Period, Value, Stock Options Exercised	$ 8,506										8,506
Issuance of Class A common shares upon conversion of Class B common shares (in shares)										(360,006)													2,250,000	11,597,654					(2,250,000)
Stock issued during period, value, conversion of convertible securities	0									$ (10,755)				$ 10,754										$ 1
Stock issued during period, shares, restricted stock award, net of forfeitures (in shares)																				7,678,184
Issuance of common stock (in shares)									835,011																	25,000,000
Stock issued during period, value, new issues	24,942				$ 73,766				$ 24,942							$ 73,762										$ 4
ELOC program fee settled in common stock (in shares)																				250,000
ELOC program fee settled in common stock	915										915
Issuance of common stock under the Sales Agreement, net of issuance costs (in shares)																				5,805,995
Issuance of common stock under the Sales Agreement, net of issuance costs	12,412										12,411									$ 1
Issuance of common stock warrants	4,136										4,136
Issuance of ESPP (in shares)																				478,023
Issuances of ESPP	863										863
Stock-based compensation	27,931										27,931
Net loss	(88,937)																	(88,937)
Other comprehensive income	199																199
Balance at the end (in shares) at Dec. 31, 2023																			216,943,349	216,943,349							37,485,408	37,485,408
Balance at the end at Dec. 31, 2023	$ 28,168								$ 14,187		606,135						199	(592,379)		$ 22								$ 4
Balance at the ending (in shares) at Dec. 31, 2023	475,005								475,005
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)	9,806,309																			17,750,154
Stock Issued During Period, Value, Stock Options Exercised	$ 29,685										29,685
Net exercise of outstanding warrants (in shares)						2,272,023
Stock issued during period values net exercise of outstanding warrants	23										23
Issuance of Class A common shares pursuant to the business combination (in shares)																					5,794,187	5,959,050
Stock issued in acquisitions		$ 9,876	$ 23,920									$ 9,875	$ 23,919								$ 1	$ 1
Issuance of Class A common shares upon conversion of Class B common shares (in shares)										(475,005)													4,950,000	16,624,215					(4,950,000)
Stock issued during period, value, conversion of convertible securities	0									$ (14,187)				$ 14,186									$ 1	$ 1					$ (1)
Stock issued during period, shares, restricted stock award, net of forfeitures (in shares)																				2,033,156
Issuance of common stock (in shares)																										85,826,406
Stock issued during period, value, new issues					$ 396,694											$ 396,685										$ 9
Issuance of Class A common stock to settle obligations under Amelia Debt (in shares)								2,943,917
Issuance of Class A common stock to settle obligations under Amelia Debt	11,817										11,817
Stock-based compensation	33,145										33,145
Net loss	(350,681)																	(350,681)
Other comprehensive income	6																6
Balance at the end (in shares) at Dec. 31, 2024																			361,096,457	361,096,457							32,535,408	32,535,408
Balance at the end at Dec. 31, 2024	$ 182,653								$ 0		$ 1,125,470						$ 205	$ (943,060)		$ 35								$ 3
Balance at the ending (in shares) at Dec. 31, 2024	0								0